143 related articles for article (PubMed ID: 11558582)
1. Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol.
Narimatsu S; Arai T; Masubuchi Y; Horie T; Hosokawa M; Ueno K; Kataoka H; Yamamoto S; Ishikawa T; Cho AK
Biol Pharm Bull; 2001 Sep; 24(9):988-94. PubMed ID: 11558582
[TBL] [Abstract][Full Text] [Related]
2. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.
Narimatsu S; Arai T; Watanabe T; Masubuchi Y; Horie T; Suzuki T; Ishikawa T; Tsutsui M; Kumagai Y; Cho AK
Chem Res Toxicol; 1997 Mar; 10(3):289-95. PubMed ID: 9084908
[TBL] [Abstract][Full Text] [Related]
3. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
5. Role of the CYP2D subfamily in metabolism-dependent covalent binding of propranolol to liver microsomal protein in rats.
Masubuchi Y; Narimatsu S; Hosokawa S; Suzuki T
Biochem Pharmacol; 1994 Nov; 48(10):1891-8. PubMed ID: 7986200
[TBL] [Abstract][Full Text] [Related]
6. In-vitro metabolic interaction of bunitrolol enantiomers in rabbit liver microsomes.
Narimatsu S; Mizukami T; Huang Y; Masubuchi Y; Suzuki T
J Pharm Pharmacol; 1996 Nov; 48(11):1185-9. PubMed ID: 8961170
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 enzymes involved in the enhancement of propranolol N-desisopropylation after repeated administration of propranolol in rats.
Narimatsu S; Mochida M; Matsumoto T; Masubuchi Y; Horie T; Nagata K; Funae Y; Cho AK; Suzuki T
Chem Biol Interact; 1996 Sep; 101(3):207-24. PubMed ID: 8870689
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a chemically reactive propranolol metabolite that binds to microsomal proteins of rat liver.
Narimatsu S; Watanabe T; Masubuchi Y; Horie T; Kumagai Y; Cho AK; Imaoka S; Funae Y; Ishikawa T; Suzuki T
Chem Res Toxicol; 1995; 8(5):721-8. PubMed ID: 7548755
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein.
Masubuchi Y; Araki J; Narimatsu S; Suzuki T
Biochem Pharmacol; 1992 Jun; 43(12):2551-7. PubMed ID: 1632813
[TBL] [Abstract][Full Text] [Related]
10. Stereoselectivity in bunitrolol 4-hydroxylation in liver microsomes from marmosets and Japanese monkeys.
Narimatsu S; Gotoh M; Masubuchi Y; Horie T; Ohmori S; Kitada M; Kageyama T; Asaoka K; Yamamoto I; Suzuki T
Biol Pharm Bull; 1996 Nov; 19(11):1429-33. PubMed ID: 8951158
[TBL] [Abstract][Full Text] [Related]
11. Catalytic specificity of CYP2D isoforms in rat and human.
Hiroi T; Chow T; Imaoka S; Funae Y
Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561
[TBL] [Abstract][Full Text] [Related]
12. Development of a high-performance liquid chromatographic method for the analysis of enatiomer/enantiomer interaction in oxidative metabolism of bunitrolol in rat liver microsomes.
Narimatsu S; Huang Y; Mizukami T; Masubuchi Y; Suzuki T
Anal Biochem; 1994 Oct; 222(1):256-61. PubMed ID: 7856858
[TBL] [Abstract][Full Text] [Related]
13. Inhibition and induction of cytochrome P450 isozymes after repetitive administration of imipramine in rats.
Masubuchi Y; Takahashii C; Fujio N; Horie T; Suzuki T; Imaoka S; Funae Y; Narimatsu S
Drug Metab Dispos; 1995 Sep; 23(9):999-1003. PubMed ID: 8565792
[TBL] [Abstract][Full Text] [Related]
14. A possible mechanism of the impairment of hepatic microsomal monooxygenase activities after multiple administration of propranolol in rats.
Masubuchi Y; Suzuki K; Fujita S; Suzuki T
Biochem Pharmacol; 1992 Feb; 43(4):757-62. PubMed ID: 1540229
[TBL] [Abstract][Full Text] [Related]
15. Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes.
Narimatsu S; Kobayashi N; Masubuchi Y; Horie T; Kakegawa T; Kobayashi H; Hardwick JP; Gonzalez FJ; Shimada N; Ohmori S; Kitada M; Asaoka K; Kataoka H; Yamamoto S; Satoh T
Chem Biol Interact; 2000 Jun; 127(1):73-90. PubMed ID: 10903420
[TBL] [Abstract][Full Text] [Related]
16. Involvement of a cytochrome P4502D subfamily in human liver microsomal bunitrolol 4-hydroxylation.
Narimatsu S; Masubuchi Y; Hosokawa S; Ohmori S; Kitada M; Suzuki T
Biol Pharm Bull; 1994 Jun; 17(6):803-7. PubMed ID: 7951142
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of mutual metabolic inhibition of lidocaine and propranolol in rat liver microsomes.
Suzuki T; Ishida R; Matsui S; Masubuchi Y; Narimatzu S
Biochem Pharmacol; 1993 Apr; 45(7):1528-30. PubMed ID: 8471076
[TBL] [Abstract][Full Text] [Related]
18. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
